Abstract
Objectives: Re-infection after treatment for Chlamydia trachomatis or Neisseria gonorrhoeae reduces the effect of control interventions. We explored the impact of delays in partner treatment on the expected probability of re-infection of index cases using a mathematical model. Methods: We used previously reported parameter distributions to calculate the probability that index cases would be re-infected by their untreated partners. We then assumed different delays between index case and partner treatment to calculate the probabilities of re-infection. Results: In the absence of partner treatment, the medians of the expected re-infection probabilities are 19.4% (interquartile range (IQR) 9.2-31.6%) for chlamydia and 12.5% (IQR 5.6-22.2%) for gonorrhoea. If all current partners receive treatment three days after the index case, the expected re-infection probabilities are 4.2% (IQR 2.1-6.9%) for chlamydia and 5.5% (IQR 2.6-9.5%) for gonorrhoea. Conclusions: Quicker partner referral and treatment can substantially reduce re-infection rates for chlamydia and gonorrhoea. The formula we used to calculate re-infection rates can be used to inform the design of randomised controlled trials of novel partner notification technologies like accelerated partner therapy.
Connections
Explore this paper’s authors, topics and related work.
Building this map preview
BZPEER is loading the nearby papers, people, topics and institutions for this page.
Reviews 0
Write a review
No reviews yet.
Discussion 0
Add a comment
No comments yet.